Clinical Trials Logo

Arthritis, Rheumatoid clinical trials

View clinical trials related to Arthritis, Rheumatoid.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT05799768 Enrolling by invitation - Obesity Clinical Trials

Ketogenic Diet in Rheumatoid Arthritis (RA)

KETORA
Start date: April 20, 2023
Phase: N/A
Study type: Interventional

This is a 6-week ketogenic diet (KD) intervention where participants with rheumatoid arthritis (RA) will follow a KD plan, supervised and monitored by a dietician. Participants will be provided extensive educational and ongoing support on the KD, including personalized coaching with the ability to text a dietitian at any time and expect a response within 12 hours. Diet adherence and progress will be assessed daily using at-home blood ketone/glucose monitors, along with diet records. Participants will fill out health related questionnaires and undergo assessments of body composition, RA disease activity. This study also includes blood draws and fat biopsy of the abdominal region.

NCT ID: NCT05727488 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

SARAH Exercise Program in Patients With Rheumatoid Arthritis

Start date: November 16, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effectiveness of the SARAH home exercise program to be applied for 12 weeks on wrist proprioception and hand functions in adult patients with rheumatoid arthritis.

NCT ID: NCT05244824 Enrolling by invitation - Clinical trials for Arthritis, Rheumatoid

Adaptation of EDAQ Into Turkish, Examining The Reliability and Validity For People With RA

Start date: March 30, 2021
Phase:
Study type: Observational

The aim of the study is to adapt the Evaluation of Daily Activity Questionnaire into Turkish language, and to examine the reliability and validity for people with rheumatoid arthritis.

NCT ID: NCT05241639 Enrolling by invitation - Clinical trials for RA - Rheumatoid Arthritis

Pentacam Study of the Cornea in RA Patients

Start date: June 11, 2021
Phase:
Study type: Observational

To evaluate the effect of rheumatoid arthritis (RA) activity on the corneal densitometry, corneal curvature (CC), central corneal thickness (CCT), and lens densitometry by Pentacam and compared these parameters with those of age-matched healthy control subjects

NCT ID: NCT04899895 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

Rheumatology Biorepository

Start date: March 10, 2021
Phase:
Study type: Observational

The Biorepository is a prospective observational cohort study for patients under the care of a licensed physician or qualified physician extender. Target minimum enrollment is approximately 3,000 patients within the first 5 years of the study with no defined upper limit of enrollment. Sites from Corrona's current North America network will be asked to participate. Participating sites and subjects will not receive results from any laboratory testing conducted on the Samples. Personal identifying information will not be collected along with the Samples. Subjects will provide informed consent to contribute Samples to include blood (serum, plasma, whole blood) to the Biorepository. In the future, Subjects may be asked to contribute other samples (i.e. saliva, urine, stool) and an additional informed consent will be obtained. Subjects will retain the right to withdraw their consent for use of their Samples at any time. In such case, Corrona will destroy any unused/remaining Samples in its possession.

NCT ID: NCT04839081 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

Neuropathic Hand Pain in Rheumatoid Arthritis

Start date: April 26, 2021
Phase:
Study type: Observational

Investigators have aimed to estimate prevalence of neuropathic hand pain in RA patients and it's relation with sleep quality and sensory thresholds. For this purpose a case-control study design was planned. Age- and sex-matched control subjects will be chosen among individuals submitted to out-patient clinic with the complaint of nociceptive/mechanical pain other than in hand, lasting more than three months

NCT ID: NCT04638426 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis

Start date: September 10, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this clinical trial is to determine the optimal dose of HL237 tablets in rheumatoid arthritis patients by comparing the efficacy and safety of the three dose groups of HL237 tablets and the control group.

NCT ID: NCT04454034 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis of Ankle

Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis

Start date: August 1, 2019
Phase:
Study type: Observational

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic and aggressive polyarthritis. The prevalence of RA in China is about 0.42%. Arthroscopic synovectomy (AS) is an important method to save the function of joint in the treatment of refractory RA. The clinical trial is to study the value of AS combine with DMARDs in the early stage of refractory RA.

NCT ID: NCT03802890 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

Microbial Dysbiosis in Rheumatoid Arthritis

MyRA
Start date: February 1, 2019
Phase:
Study type: Observational

The MyRA study will primarily investigate whether there are associations between the structure and function of the gut microbiome and response to methotrexate in early rheumatoid arthritis patients. The microbiome will be characterised via shotgun metagenomic sequencing of microbial DNA present in stool samples taken during the participant's first 6 months of taking methotrexate.

NCT ID: NCT03506165 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

Relationship of Periodontitis and Cardiovascular Risk in Patients With Rheumatoid Arthritis

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Rheumatoid arthritis (RA) is one of the most common autoimmune inflammatory arthritis affecting 0.5 to 1% population worldwide characterized by synovitis, increased inflammatory markers and progressive bone and cartilage erosion. RA is associated with an increased cardiovascular morbidity and mortality compared with the general population.